New England Journal Of Medicine Publishes Results Of Global, Multicenter Enrgy Study Evaluating Zenocutuzumab-Zbco (BIZENGRI®) In NRG1+ Cancer
Zenocutuzumab helps fill an important need for patients with advanced pancreatic cancer and NSCLC with NRG1 gene fusions, said Alison Schram M.D., ...
Healio1h
Study: Unexpected infant deaths increased in recent years
Although infant mortality rates have declined since 1999, there was a recent spike in sudden unexpected infant deaths from ...
rheumatologyadvisor8h
Many Very Preterm Infants Experience Pain
HealthDay News — Many very preterm infants experience pain, according to a study published online Jan. 21 in Pain. Hillary Graham, from the Karolinska Institutet in Stockholm, and colleagues explored ...
New England Journal Of Medicine Publishes: Efficacy Of Zenocutuzumab In NRG1 Fusion-Positive Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinic ...